Biologics Companies
The biologics industry was experiencing significant growth, with several companies leading the market in the development and manufacturing of biologic products, including therapeutic proteins, monoclonal antibodies, and vaccines.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
*Disclaimer: List of key companies in no particular orderLatest biologics Companies Update
-
Oct 2023: A financial investment company called Pacer Advisors Inc. most recently increased its ownership of Envista Holdings Co. during the second quarter of this year. Following the most recent information filed with the Securities and Exchange Commission (SEC), Pacer Advisors Inc. acquired 28,700 business shares for approximately $970,000. The American-based Envista Holdings Corporation is a global creator, producer, marketer, and distributor of dental goods. Two divisions comprise the company's operations: Specialty Products and technologies and Equipment and consumables. Envista provides a range of dental goods under its Specialty goods and technologies business, including guided surgery systems, biomaterials, pre-fabricated and custom-built prosthetics, and dental implant systems. -
Feb 2023: The AI-driven Ceph Analysis Orthodontic Software will be available by Owandy Radiology Inc., a market leader in producing dental radiology gear and imaging software. The orthodontic software is offered as an extra module for Owandy's I-Max Ceph panoramic digital radiography equipment. It comes with a basic or advanced feature set. Both packages have an artificial intelligence engine for orthodontic evaluation and treatment planning that has been tested in the market to produce predictable results. Owandy's AI-powered tracing tool quickly and accurately identifies planes, silhouettes, and soft and hard tissue features on lateral or PA radiographs. From the present skeleton age to a selected skeletal age, the skull tracing will be tracked via the skull development projection feature. Forecasts to maturity are conceivable.List of biologics Key companies in the market - AbbVie Inc.
- Pfizer Inc.
- AstraZeneca
- Novartis AG
- Hoffman-La Roche AG
- Bayer AG
- Amgen
- Sanofi
- Eli Lilly and Company
- GlaxoSmithKline Plc
- Celltrion Inc.
- Samsung Biologics Co. Ltd.
- G. Chem Ltd.
Biologics Market Highlights:
Biologics Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
